GlaxoSmithkline Consumer Healthcare today posted a 13 per cent increase in its net profit at Rs 60.02 crore for the third quarter ended September 30, over the same period a year earlier.
Total income of the company rose to Rs 510.27 crore during the July-September quarter of the current financial year from Rs 436.50 crore of the corresponding quarter last financial year, GlaxoSmithkline Consumer said in a filing to the Bombay Stock Exchange (BSE).
For the nine-month ended September 30, the food products maker posted a net profit of Rs 199.10 crore, up 28 per cent from Rs 155.75 crore registered in the same period previous year.
Shares of GlaxoSmithkline Consumer were trading at Rs 1,241.10, up 1.72 per cent in the late afternoon trade on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app